CELGENE CORPORATION v. TEVA PHARMACEUTICALS USA, INC. et al
| CELGENE CORPORATION |
| TEVA PHARMACEUTICALS USA, INC. and ACTAVIS LLC |
| 3:2018cv11215 |
| June 28, 2018 |
| US District Court for the District of New Jersey |
| Trenton Office |
| XX US, Outside State |
| Douglas E Arpert |
| Michael A Shipp |
| Patent - Abbreviated New Drug Application(ANDA) |
| 15 U.S.C. ยง 1126 |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on June 28, 2018. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 2 Corporate Disclosure Statement by CELGENE CORPORATION. (LIZZA, CHARLES) |
| Filing 1 COMPLAINT against ACTAVIS LLC, TEVA PHARMACEUTICALS USA, INC. ( Filing and Admin fee $ 400 receipt number 0312-8850298), filed by CELGENE CORPORATION. (Attachments: #1 Civil Cover Sheet)(LIZZA, CHARLES) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the New Jersey District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
